platinum has been researched along with Thromboembolism, Venous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Chesney, J; Kloecker, G; Maharaj, S; Redman, R; Rojan, A | 1 |
| Fujita, A; Fushimi, K; Iwai, C; Jo, T; Konishi, T; Matsui, H; Michihata, N; Yasunaga, H | 1 |
2 other study(ies) available for platinum and Thromboembolism, Venous
| Article | Year |
|---|---|
Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.
Topics: Humans; Immunotherapy; Platinum; Risk Factors; Stroke; Venous Thromboembolism | 2022 |
Thrombotic risk of platinum combination chemotherapy with and without immune checkpoint inhibitors for advanced non-small cell lung cancer: a nationwide inpatient database study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Humans; Immune Checkpoint Inhibitors; Inpatients; Lung Neoplasms; Platinum; Retrospective Studies; Thrombosis; Venous Thromboembolism | 2023 |